Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain
Status:
Recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, parallel group, placebo controlled trial to
evaluate the contribution of Triamcinolone Hexacetonide (TH) to pain relief, both in terms of
magnitude and duration, when used within a single injection of Cingal® compared to a single
injection of TH in subjects with OA of the knee.